MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE
Clinical trials for MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE explained in plain language.
Never miss a new study
Get alerted when new MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE trials appear
Sign up with your email to follow new studies for MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can a special diet and step counting slow early blood cancer?
Knowledge-focused Not yet recruitingThis small pilot study will test whether a Korean-style Mediterranean diet and daily step tracking are feasible for people with MGUS or smoldering myeloma, two early blood conditions that can sometimes progress to cancer. Twenty participants will follow the diet for 12 weeks and …
Matched conditions: MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE
Phase: NA • Sponsor: Seoul National University Bundang Hospital • Aim: Knowledge-focused
Last updated Jun 16, 2026 22:36 UTC
-
Massive study to unravel mysterious Immune-Blood disorder link
Knowledge-focused Not yet recruitingThis study will follow 5,000 adults with immune system problems to see if they also have hidden blood cell mutations (clonal hematopoiesis), including the rare VEXAS syndrome. Researchers aim to track how often these immune issues appear with blood disorders. No new treatments ar…
Matched conditions: MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 15, 2026 19:04 UTC